¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ°íÇ÷¾ÐÇÐȸ Æó°íÇ÷¾Ð¿¬±¸È¸ Á¦5ȸ ¿¬·ÊÇмú½ÉÆ÷Áö¾ö : 2020-10-31

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ°íÇ÷¾ÐÇÐȸ Æó°íÇ÷¾Ð¿¬±¸È¸ Á¦5ȸ ¿¬·ÊÇмú½ÉÆ÷Áö¾ö : 2020-10-31
±³À°ÀÏÀÚ : 2020-10-31
±³À°Àå¼Ò : ºû°íÀ» Àü³²´ëÇб³º´¿ø 2Ãþ ´ë°­´ç  
±³À°ÁÖÁ¦ : ´ëÇÑ°íÇ÷¾ÐÇÐȸ Æó°íÇ÷¾Ð¿¬±¸È¸ Á¦5ȸ ¿¬·ÊÇмú½ÉÆ÷Áö¾ö      
ÁÖÃÖ±â°ü : ´ëÇÑ°íÇ÷¾ÐÇÐȸ
´ã´çÀÚ : Á¤º° 
¿¬¶ôó : 02-565-3350  
À̸ÞÀÏ : ksh2@koreanhypertension.org      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ±¤ÁÖ±¤¿ª½Ã
±³À°½Ã°£ : 7 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 10,000¿ø      
ºñ°í »çÀüµî·Ïºñ 10,0000¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 09:00~09:15 Persistent pulmonary hypertension of newborn  ¼ÛÀº¼Û(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 09:15~09:30 Bronchopulmonary dysplasia and pulmonary hypertension in preemies  °íÈÆ(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 09:30~09:45 Pulmonary hypertension in young adults  ÃÖÁ¤Çö(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 09:45~10:00 Pulmonary hypertension in middle ages  ±èÇö¼÷(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 10:00~10:15 Pulmonary hypertension in elderly  ÀÌÀç½Â(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 10:15~10:30 Discussion  Á¤ÁßÈ­,¾È°æÁø,À̼±È­(Á¶¼±ÀÇ´ë,°¡ÃµÀÇ´ë,ÀüºÏÀÇ´ë) 
È޽Ġ10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 10:30~10:50 Coffee break  () 
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 10:50~11:05 Phosphodiesterase 5 inhibitor  Àå¼ÒÀÍ(¼¼Á¾º´¿ø) 
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 11:05~11:20 Endothelin receptor blocker  ±èÅÂÁ¾(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 11:20~11:35 Prostanoid, parenteral  ±è±â¹ü(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 11:35~11:50 Prostanoid, oral  ¹ÚÀçÇü(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 11:50~12:05 Best combination treatment strategy for effective treatment  ±è°æÈñ(¼¼Á¾º´¿ø) 
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 12:05~12:20 Discussion  ½Å¼ºÈñ,³ªÁø¿À,¼ÕÁ¤¿ì,Çã¶õ(ÀÎÇÏÀÇ´ë,°í·ÁÀÇ´ë,¿øÁÖÀÇ´ë,ÇѾçÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 12:20~13:20 Lunch  () 
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 13:20~13:35 Indication and completion of lung transplantation, in practice  ±èȣö(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 13:35~13:50 Outcomes of lung transplantation in the world and Korea  À念¿ì(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 13:50~14:05 Follow-up guideline after lung transplantation including rehabilitation  ±è¼ÛÀÌ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 14:05~14:20 Heart and lung co-transplantation  ¹Ú±¹¾ç(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 14:20~14:35 Pearls and Pitfalls in lung transplantation from my experience  ÀÌÁø±¸(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 14:35~14:50 Discussion  À̼ö¿ë,±èÇöÁø(ºÎ»êÀÇ´ë,ÇѾçÀÇ´ë) 
È޽Ġ10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 14:50~15:10 Coffee break  () 
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 15:10~15:25 How to find new target in PAH by microarray?  º¯°æÈñ(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 15:25~15:40 How to visualize macrophage mediated inflammation in pulmonary circulation?  ÆØÁøö(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 15:40~15:55 Why we need deep phenotyping in PAH on the era of multi-omics?  Á¤¿íÁø(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 15:55~16:10 Discussion  ¼Õ±¹Èñ,ÀÌÁÖÈñ,¿À¼¼¿¬(°¡ÃµÀÇ´ë,ÃæºÏÀÇ´ë,À̱濩¾Ï´ç´¢¿¬±¸¿ø) 
È޽Ġ10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 16:10~16:20 Interesting case discussions with brief review-case1  Â÷½½±â(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 16:20~16:30 Interesting case discussions with brief review-case2  ¹Ú¼öÁ¤(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 16:30~16:40 Interesting case discussions with brief review-case3  ÀåÇ×Á¦(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 16:40~16:50 Interesting case discussions with brief review-case4  ±èÁö³ª(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 16:50~17:00 Interesting case discussions with brief review-case5  ÀÌâÈÆ(¿ø±¤ÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ 2Ãþ ´ë°­´ç 17:00~17:10 Interesting case discussions with brief review-case6  ³ª½Â¿ø(¿ï»êÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ°íÇ÷¾ÐÇÐȸ Æó°íÇ÷¾Ð¿¬±¸È¸ Á¦5ȸ ¿¬·ÊÇмú½ÉÆ÷Áö¾ö : 2020-10-31""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) 2020³â Á¦59Â÷ ´ëÇÑÇÙÀÇÇÐȸ Ãß°èÇмú´ëȸ ¹× ÃÑȸ : 2020-10-31
´ÙÀ½±Û (¿Â¶óÀÎ) ´ëÇÑÀçÈ°ÀÇÇÐȸ 2020³â Ãß°èÇмú´ëȸ : 2020-10-30
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20589 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GI Cancer 2024 : 2024-06-14 0 57 2024-04-29
20588 ¼­¿ï ´ëÇÑ°ñ´ë»çÇÐȸ SSBH 2024 (The 12th Seoul Symposium on Bone Health)&Á¦36Â÷ Ãá°èÇмú´ëȸ 2ÀÏÂ÷ : 2024-06-14 0 54 2024-04-29
20587 ¼­¿ï ´ëÇѽÅÀåÇÐȸ APCN & KSN 2024 2ÀÏÂ÷ : 2024-06-14 0 35 2024-04-29
20586 °æºÏ 2024 ´ëÇÑÆó¾ÏÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-14 0 48 2024-04-29
20585 ¼­¿ï ´ëÇѽÅÀåÇÐȸ APCN & KSN 2024 1ÀÏÂ÷ : 2024-06-13 0 55 2024-04-29
20584 ¼­¿ï ´ëÇÑ°ñ´ë»çÇÐȸ SSBH 2024 (The 12th Seoul Symposium on Bone Health)&Á¦36Â÷ Ãá°èÇмú´ëȸ 1ÀÏÂ÷ : 2024-06-13 0 53 2024-04-29
20583 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-ÃÖ½ÅÇü º¸Ã»±â¿Í ¸ÂÃãÇü º¸Ã»±â ó¹æ¿ä·É : 2024-06-13 0 40 2024-04-29
20582 ¼­¿ï °­³²¼¼ºê¶õ½º ¾È°ú Áö¿ªÀÇ»çÁý´ãȸ(³­Ä¡¼º °¢¸· Áúȯ) : 2024-06-11 0 61 2024-04-29
20581 ¼­¿ï [¿Â¶óÀÎ] Á¦274ȸ ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ¿ù·Ê ÇмúÁý´ãȸ(Æó±â´É°ú ±â°üÁö°ú¹Î¼º) : 2024-06-11 0 41 2024-04-29
20580 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø [¿Â¶óÀÎ] Á¦ 26 ȸ ¿Ü·¡Â÷¿øÀÇ ¼Ò¾Æû¼Ò³â°ú ÀÓ»ó : 2024-06-09 0 44 2024-04-29
20579 ¼­¿ï °í·Á´ëÇб³±¸·Îº´¿ø ¼øȯ±â³»°ú 16ȸ KOALA Symposium 2024 : 2024-06-09 0 40 2024-04-29
20578 ¼­¿ï ´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ (¿Â¶óÀÎ) Á¦3ȸ ¼ö¸é°øµ¿½ÉÆ÷Áö¾ö : 2024-06-09 0 56 2024-04-29
20577 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ 2024 ´ç´¢º´ °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-09 0 66 2024-04-29
20576 ¼­¿ï 2024 ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-08 0 59 2024-04-29
20575 ¼­¿ï 2024 »ó¹Ý±â ´ëÇÑÇ÷¾×ÇÐȸ ´Ù¹ß°ñ¼öÁ¾¿¬±¸È¸ ½ÉÆ÷Áö¾ö(2024 »ó¹Ý±â KMMWP workshop & Àӻ󿬱¸¸ðÀÓ) : 2024-06-08 0 44 2024-04-29
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷